Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9 | Semantic Scholar
Endocrinology and Metabolism
References in EGF-A peptides: A promising strategy for PCSK9 inhibition - Atherosclerosis
Inclisiran - an overview | ScienceDirect Topics
Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field? | Journal of the American College of Cardiology
New opportunity for cholesterol lowering: inclisiran
NEJM 在Twitter 上："Perspective: Oligonucleotide Therapeutics (image: Inclisiran Chemical Configuration and Mechanism of Action) https://t.co/M5N3RBrKZa https://t.co/hTbXXUS0n2" / Twitter
Frontiers | Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries | Cardiovascular Medicine
Inclisiran: mechanism of action. Inclisiran is a long-acting, synthetic... | Download Scientific Diagram
PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes. | Semantic Scholar
Effectiveness and Safety of Inclisiran, A Novel Long-Acting RNA Therapeutic Inhibitor of Proprotein Convertase Subtilisin/Kexin 9 - American Journal of Cardiology
A) Simplified overview of mechanism of action by Inclisiran.... | Download Scientific Diagram
Targeting the peptidase PCSK9 to reduce cardiovascular risk: Implications for basic science and upcoming challenges - Nishikido - 2021 - British Journal of Pharmacology - Wiley Online Library
Inclisiran (Leqvio)
PDF) Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9
Inclisiran—New hope in the management of lipid disorders? - Journal of Clinical Lipidology
siRNA drug Leqvio (inclisiran) to lower cholesterol: Trends in Pharmacological Sciences
Statins, PCSK9 agents, and Inclisiran | Cardiometabolic CE
siRNA drug Leqvio (inclisiran) to lower cholesterol: Trends in Pharmacological Sciences
Frontiers | PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects | Physiology
New Pharmacological Approaches to Target PCSK9 | SpringerLink
A New Approach to PCSK9 Therapeutics | Circulation Research
The Evolving Future of PCSK9 Inhibitors - ScienceDirect
Leqvio (inclisiran) for the Treatment of Hypercholaesterolemia
A New Approach to PCSK9 Therapeutics | Circulation Research
Inclisiran - Lappin - 2021 - Practical Diabetes - Wiley Online Library
Therapeutic siRNA: state of the art | Signal Transduction and Targeted Therapy
